BYLOZA M TAB

About

BYLOZA M TAB is an oral anti-diabetic medication, likely a combination product containing Metformin and another anti-diabetic agent (e.g., an SGLT2 inhibitor or DPP-4 inhibitor). Metformin works primarily by decreasing glucose production by the liver, reducing intestinal absorption of glucose, and improving insulin sensitivity. The additional component complements this action by either increasing glucose excretion via the kidneys or enhancing insulin secretion and action.

This combination therapy is prescribed for adults with type 2 diabetes mellitus to improve glycemic control when diet and exercise alone are insufficient, or when monotherapy with Metformin or the other agent does not provide adequate control. It helps to lower blood sugar levels, reduce HbA1c, and manage the long-term complications associated with diabetes, thereby improving overall metabolic health.

Uses

• Improving glycemic control in type 2 diabetes mellitus.
• Lowering fasting and post-meal blood sugar levels.
• Reducing HbA1c levels.
• Used as an adjunct to diet and exercise.

Directions For Use

Take one tablet orally, usually once or twice daily with meals, as directed by your doctor.

Benefits

• Effectively lowers blood glucose levels.
• Improves insulin sensitivity.
• May aid in weight management (Metformin component).
• Reduces risk of diabetes complications.
• Convenient combination therapy.
• Well-established efficacy.

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Vomiting
• Metallic taste in mouth
• Headache
• Dizziness
• Hypoglycemia (especially with other agents)
• Lactic acidosis (rare, serious)
• Fatigue
• Weakness
• Urinary tract infections (if SGLT2 component)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption due to increased risk of lactic acidosis, especially with Metformin.
• Pregnancy - Not generally recommended during pregnancy; insulin is often preferred. Consult a doctor.
• Breastfeeding - Metformin passes into breast milk; consult a doctor. Other components may vary.
• Liver - Use with caution in patients with liver impairment; monitor liver function. Metformin is contraindicated in severe liver disease.
• Kidney - Contraindicated in severe kidney impairment due to risk of lactic acidosis (Metformin). Dose adjustment needed for moderate impairment.
• Lung - Use with caution in conditions causing hypoxia (e.g., severe lung disease) due to increased risk of lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.